SXTP logo

SXTP Stock Overview

Profile

Full Name:

60 Degrees Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 12, 2023

Indexes:

Not included

Description:

60 Degrees Pharmaceuticals (SXTP) focuses on developing and commercializing innovative treatments for rare diseases. The company aims to improve patient outcomes through advanced therapies, particularly in areas with high unmet medical needs. Their commitment to research and development drives their mission to enhance healthcare solutions.

Key Details

Price

$1.67

Annual Revenue

$253.60 K(+13.62% YoY)

Annual EPS

-$59.40(+10.80% YoY)

Annual ROE

-77.32%

Beta

0.35

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 24, 2025

Analyst ratings

Recent major analysts updates

Feb 25, 25 HC Wainwright & Co.
Neutral
Jan 10, 25 HC Wainwright & Co.
Neutral
Dec 23, 24 HC Wainwright & Co.
Neutral
Dec 11, 24 HC Wainwright & Co.
Neutral
Nov 15, 24 HC Wainwright & Co.
Neutral
Sep 13, 24 HC Wainwright & Co.
Neutral
Aug 15, 24 HC Wainwright & Co.
Neutral
Jun 6, 24 HC Wainwright & Co.
Neutral
Apr 3, 24 HC Wainwright & Co.
Neutral
Oct 20, 23 HC Wainwright & Co.
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for 60 Degrees Pharmaceuticals?
  • Does 60 Degrees Pharmaceuticals pay dividends?
  • What sector is 60 Degrees Pharmaceuticals in?
  • What industry is 60 Degrees Pharmaceuticals in?
  • What country is 60 Degrees Pharmaceuticals based in?
  • When did 60 Degrees Pharmaceuticals go public?
  • Is 60 Degrees Pharmaceuticals in the S&P 500?
  • Is 60 Degrees Pharmaceuticals in the NASDAQ 100?
  • Is 60 Degrees Pharmaceuticals in the Dow Jones?
  • When does 60 Degrees Pharmaceuticals report earnings?
  • Should I buy 60 Degrees Pharmaceuticals stock now?

What is the ticker symbol for 60 Degrees Pharmaceuticals?

The ticker symbol for 60 Degrees Pharmaceuticals is NASDAQ:SXTP

Does 60 Degrees Pharmaceuticals pay dividends?

No, 60 Degrees Pharmaceuticals does not pay dividends

What sector is 60 Degrees Pharmaceuticals in?

60 Degrees Pharmaceuticals is in the Healthcare sector

What industry is 60 Degrees Pharmaceuticals in?

60 Degrees Pharmaceuticals is in the Biotechnology industry

What country is 60 Degrees Pharmaceuticals based in?

60 Degrees Pharmaceuticals is headquartered in United States

When did 60 Degrees Pharmaceuticals go public?

60 Degrees Pharmaceuticals's initial public offering (IPO) was on July 12, 2023

Is 60 Degrees Pharmaceuticals in the S&P 500?

No, 60 Degrees Pharmaceuticals is not included in the S&P 500 index

Is 60 Degrees Pharmaceuticals in the NASDAQ 100?

No, 60 Degrees Pharmaceuticals is not included in the NASDAQ 100 index

Is 60 Degrees Pharmaceuticals in the Dow Jones?

No, 60 Degrees Pharmaceuticals is not included in the Dow Jones index

When does 60 Degrees Pharmaceuticals report earnings?

The date for 60 Degrees Pharmaceuticals's next earnings report has not been announced yet

Should I buy 60 Degrees Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions